Ginsenoside compound K reduces the progression of Huntington's disease via the inhibition of oxidative stress and overactivation of the ATM/AMPK pathway
Open Access
- 11 November 2021
- journal article
- research article
- Published by Elsevier BV in Journal of Ginseng Research
- Vol. 46 (4), 572-584
- https://doi.org/10.1016/j.jgr.2021.11.003
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Science and Technology, Taiwan (MOST 106-2311-B-029-005, MOST 107-2311-B-029-002, MOST 109-2622-B-029-001)
- Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH 108-8R61, KMUH 109-9R72)
This publication has 66 references indexed in Scilit:
- Red ginseng abrogates oxidative stress via mitochondria protection mediated by LKB1-AMPK pathwayBMC Complementary and Alternative Medicine, 2013
- Effects of Panax ginseng in Neurodegenerative DiseasesJournal of Ginseng Research, 2012
- Role of AMPK in UVB-induced DNA damage repair and growth controlOncogene, 2012
- Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer's disease: Implications for early intervention and therapeuticsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- Nuclear translocation of AMPK-α1 potentiates striatal neurodegeneration in Huntington’s diseaseThe Journal of cell biology, 2011
- Dysregulated brain creatine kinase is associated with hearing impairment in mouse models of Huntington diseaseJCI Insight, 2011
- Ginsenosides protect striatal neurons in a cellular model of Huntington's diseaseJournal of Neuroscience Research, 2009
- Etoposide Induces ATM-Dependent Mitochondrial Biogenesis through AMPK ActivationPLOS ONE, 2008
- AMP-activated protein kinase signaling in metabolic regulationJCI Insight, 2006
- SQ/TQ cluster domains: concentrated ATM/ATR kinase phosphorylation site regions in DNA-damage-response proteinsBioEssays, 2005